Page last updated: 2024-08-21

benzydamine and am 251

benzydamine has been researched along with am 251 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avvisati, R; Badiani, A; Malavasi, E; Marinelli, S; Meringolo, M; Stendardo, E	1

Other Studies

1 other study(ies) available for benzydamine and am 251

Article	Year
Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action. Addiction biology, 2018, Volume: 23, Issue:2 Topics: Administration, Intravenous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Benzydamine; Cocaine; Dopamine Uptake Inhibitors; Excitatory Postsynaptic Potentials; Glutamic Acid; Heroin; Long-Term Synaptic Depression; Narcotics; Neural Pathways; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Self Administration; Synaptic Transmission	2018

Article

Year

Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action.

Addiction biology, 2018, Volume: 23, Issue:2

Topics: Administration, Intravenous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Benzydamine; Cocaine; Dopamine Uptake Inhibitors; Excitatory Postsynaptic Potentials; Glutamic Acid; Heroin; Long-Term Synaptic Depression; Narcotics; Neural Pathways; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Self Administration; Synaptic Transmission

2018